QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 165 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $30,128,000 | +6.2% | 1,075,207 | +4.0% | 0.01% | +12.5% |
Q3 2016 | $28,357,000 | +19.4% | 1,033,428 | -5.1% | 0.01% | +14.3% |
Q2 2016 | $23,751,000 | +9.2% | 1,088,917 | +11.8% | 0.01% | 0.0% |
Q1 2016 | $21,757,000 | -17.8% | 973,882 | +1.8% | 0.01% | -12.5% |
Q4 2015 | $26,461,000 | +5.6% | 956,984 | -1.5% | 0.01% | 0.0% |
Q3 2015 | $25,061,000 | -10.6% | 971,404 | -14.1% | 0.01% | 0.0% |
Q2 2015 | $28,024,000 | -11.1% | 1,130,522 | -9.7% | 0.01% | 0.0% |
Q1 2015 | $31,534,000 | +4.1% | 1,251,330 | -3.1% | 0.01% | 0.0% |
Q4 2014 | $30,282,000 | -0.6% | 1,290,787 | -3.5% | 0.01% | 0.0% |
Q3 2014 | $30,472,000 | -54.9% | 1,338,274 | -51.6% | 0.01% | -11.1% |
Q2 2014 | $67,602,000 | +130.1% | 2,764,920 | +98.4% | 0.01% | +12.5% |
Q1 2014 | $29,384,000 | -15.6% | 1,393,270 | -4.7% | 0.01% | -20.0% |
Q4 2013 | $34,823,000 | +10.2% | 1,462,550 | -0.9% | 0.01% | +100.0% |
Q3 2013 | $31,598,000 | +16.7% | 1,476,547 | +8.6% | 0.01% | -44.4% |
Q2 2013 | $27,076,000 | – | 1,359,916 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |